.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Healthtrust
Farmers Insurance
Accenture
McKesson
Colorcon
Medtronic
Daiichi Sankyo
Mallinckrodt

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,696,481 protect, and when does it expire?


Patent ► Subscribe protects PRESTALIA and is included in one NDA. There has been one Paragraph IV challenge on Prestalia.

This patent has forty-one patent family members in thirty-five countries.

Summary for Patent: ► Subscribe

Title: Salt of perindopril and pharmaceutical compositions containing it
Abstract:The present invention relates to a new salt of perindopril and to pharmaceutical compositions containing it, and Medicaments for treatment of hypertension and heart failure.
Inventor(s): Damien; Gerard (Orleans, FR), Lefoulon; Fran.cedilla.ois (Orleans, FR), Marchand; Bernard (Verneuil sur Seine, FR)
Assignee: Les Laboratoires Servier (Neuilly-sur-Seine, FR)
Application Number:10/371,865
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Symplmed Pharms Llc
PRESTALIA
amlodipine besylate; perindopril arginine
TABLET;ORAL205003-001Jan 21, 2015RXYesNo► Subscribe► SubscribeYY TREATMENT OF HYPERTENSION
Symplmed Pharms Llc
PRESTALIA
amlodipine besylate; perindopril arginine
TABLET;ORAL205003-002Jan 21, 2015RXYesNo► Subscribe► SubscribeYY TREATMENT OF HYPERTENSION
Symplmed Pharms Llc
PRESTALIA
amlodipine besylate; perindopril arginine
TABLET;ORAL205003-003Jan 21, 2015RXYesYes► Subscribe► SubscribeYY TREATMENT OF HYPERTENSION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway20030849► Subscribe
MexicoPA03002346► Subscribe
Morocco27115► Subscribe
South Korea100542468► Subscribe
South Korea20030082902► Subscribe
Japan3737488► Subscribe
Japan2003321493► Subscribe
Iceland2842► Subscribe
Iceland7516► Subscribe
Israel164424► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Mallinckrodt
AstraZeneca
Fish and Richardson
Citi
McKinsey
Healthtrust
QuintilesIMS
Chinese Patent Office
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot